KEGG   PATHWAY: gvr05200
Entry
gvr05200                    Pathway                                
Name
Pathways in cancer - Galeopterus variegatus (Sunda flying lemur)
Class
Human Diseases; Cancer: overview
Pathway map
gvr05200  Pathways in cancer
gvr05200

Organism
Galeopterus variegatus (Sunda flying lemur) [GN:gvr]
Gene
103589530  CASP3; caspase-3 [KO:K02187] [EC:3.4.22.56]
103590595  CASP9; caspase-9 [KO:K04399] [EC:3.4.22.62]
103597398  APPL1; DCC-interacting protein 13-alpha [KO:K08733]
103585943  CDH1; cadherin-1 [KO:K05689]
103600945  CTNNB1; catenin beta-1 isoform X1 [KO:K02105]
103602369  CTNNA1; catenin alpha-1 isoform X1 [KO:K05691]
103592403  CTNNA2; catenin alpha-2 [KO:K05691]
103604797  AXIN1; axin-1 isoform X1 [KO:K02157]
103597471  AXIN2; axin-2 isoform X1 [KO:K04385]
103608971  APC2; adenomatous polyposis coli protein 2 [KO:K02085]
103586841  APC; adenomatous polyposis coli protein isoform X1 [KO:K02085]
103595392  GSK3B; glycogen synthase kinase-3 beta isoform X1 [KO:K03083] [EC:2.7.11.26]
103592399  TCF7; transcription factor 7 isoform X1 [KO:K02620]
103585949  TCF7L1; transcription factor 7-like 1 isoform X1 [KO:K04490]
103589124  TCF7L2; transcription factor 7-like 2 isoform X1 [KO:K04491]
103593743  LEF1; lymphoid enhancer-binding factor 1 isoform X1 [KO:K04492]
103595967  BIRC5; baculoviral IAP repeat-containing protein 5 isoform X1 [KO:K08731]
103587820  MYC; myc proto-oncogene protein [KO:K04377]
103607082  CCND1; G1/S-specific cyclin-D1 [KO:K04503]
103588854  WNT1; proto-oncogene Wnt-1 [KO:K03209]
103597215  WNT2; protein Wnt-2 [KO:K00182]
103593776  WNT2B; protein Wnt-2b [KO:K00182]
103597574  WNT3; proto-oncogene Wnt-3 [KO:K00312]
103605695  protein Wnt-3a [KO:K00312]
103598980  protein Wnt-4 [KO:K00408]
103590234  WNT5B; protein Wnt-5b [KO:K00444]
103597246  WNT5A; protein Wnt-5a isoform X1 [KO:K00444]
103600246  WNT6; protein Wnt-6 isoform X1 [KO:K00445]
103609951  WNT7B; protein Wnt-7b [KO:K00572]
103590674  WNT7A; protein Wnt-7a [KO:K00572]
103588804  WNT8B; protein Wnt-8b [KO:K00714]
103605402  WNT8A; protein Wnt-8a [KO:K00714]
103597576  WNT9B; protein Wnt-9b [KO:K01064]
103605697  WNT9A; protein Wnt-9a [KO:K01064]
103607489  protein Wnt-9b-like [KO:K01064]
103588855  WNT10B; protein Wnt-10b [KO:K01357]
103600247  WNT10A; protein Wnt-10a [KO:K01357]
103590450  WNT11; protein Wnt-11 [KO:K01384]
103605007  WNT16; protein Wnt-16 isoform X1 [KO:K01558]
103596055  FZD1; frizzled-1 [KO:K02432]
103597620  FZD7; LOW QUALITY PROTEIN: frizzled-7 [KO:K02432]
103595017  FZD2; frizzled-2 [KO:K02235]
103604077  FZD3; frizzled-3 [KO:K02329]
103590315  FZD4; frizzled-4 [KO:K02354]
103586698  FZD5; frizzled-5 [KO:K02375]
103594788  FZD6; frizzled-6 [KO:K02376]
103596654  FZD9; frizzled-9 [KO:K02842]
103596735  FZD10; frizzled-10 [KO:K02842]
103588008  LRP5; low-density lipoprotein receptor-related protein 5 [KO:K03068]
103594136  LRP6; low-density lipoprotein receptor-related protein 6 [KO:K03068]
103594862  DVL1; segment polarity protein dishevelled homolog DVL-1 [KO:K02353]
103591440  DVL2; segment polarity protein dishevelled homolog DVL-2 [KO:K02353]
103593898  DVL3; segment polarity protein dishevelled homolog DVL-3 isoform X1 [KO:K02353]
103590897  FRAT1; proto-oncogene FRAT1 [KO:K03069]
103590898  FRAT2; GSK-3-binding protein FRAT2 [KO:K03096]
103603381  F2; prothrombin [KO:K01313] [EC:3.4.21.5]
103605394  AGT; angiotensinogen isoform X1 [KO:K09821]
103610123  LOW QUALITY PROTEIN: proteinase-activated receptor 1-like [KO:K03914]
103604130  F2R; LOW QUALITY PROTEIN: proteinase-activated receptor 1 [KO:K03914]
103594368  F2RL3; proteinase-activated receptor 4 [KO:K04236]
103595136  LPAR1; lysophosphatidic acid receptor 1 [KO:K04289]
103588129  LPAR2; lysophosphatidic acid receptor 2 [KO:K04291]
103599684  LPAR3; lysophosphatidic acid receptor 3 [KO:K04294]
103594330  LPAR4; lysophosphatidic acid receptor 4 [KO:K04275]
103593661  LPAR6; lysophosphatidic acid receptor 6 [KO:K04273]
103597449  AGTR1; type-1 angiotensin II receptor [KO:K04166]
103585712  GNA12; guanine nucleotide-binding protein subunit alpha-12 [KO:K04346]
103587812  GNA13; guanine nucleotide-binding protein subunit alpha-13 [KO:K04639]
103588513  ARHGEF12; rho guanine nucleotide exchange factor 12 isoform X1 [KO:K07532]
103588508  ARHGEF11; rho guanine nucleotide exchange factor 11 isoform X1 [KO:K12331]
103586090  ARHGEF1; rho guanine nucleotide exchange factor 1 [KO:K12330]
103585896  PLEKHG5; pleckstrin homology domain-containing family G member 5 isoform X1 [KO:K19464]
103584948  RHOA; transforming protein RhoA [KO:K04513]
103592848  ROCK1; rho-associated protein kinase 1 [KO:K04514] [EC:2.7.11.39]
103590666  ROCK2; rho-associated protein kinase 2 [KO:K17388] [EC:2.7.11.39]
103608094  CXCL12; stromal cell-derived factor 1 [KO:K10031]
103591817  CXCR4; C-X-C chemokine receptor type 4 [KO:K04189]
103588331  GNAI1; guanine nucleotide-binding protein G(i) subunit alpha-1 [KO:K04630]
103585560  GNAI3; guanine nucleotide-binding protein G(k) subunit alpha [KO:K04630]
103593713  GNAI2; guanine nucleotide-binding protein G(i) subunit alpha-2 isoform X1 [KO:K04630]
103585156  PTGER1; prostaglandin E2 receptor EP1 subtype [KO:K04258]
103596816  PTGER2; prostaglandin E2 receptor EP2 subtype [KO:K04259]
103589785  PTGER3; prostaglandin E2 receptor EP3 subtype [KO:K04260]
103585841  PTGER4; prostaglandin E2 receptor EP4 subtype [KO:K04261]
103608810  GNAS; guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas isoform X1 [KO:K04632]
103608866  neuroendocrine secretory protein 55 [KO:K04632]
103599611  ADCY1; adenylate cyclase type 1 [KO:K08041] [EC:4.6.1.1]
103597918  ADCY2; adenylate cyclase type 2 [KO:K08042] [EC:4.6.1.1]
103588815  ADCY3; adenylate cyclase type 3 [KO:K08043] [EC:4.6.1.1]
103590144  ADCY4; adenylate cyclase type 4 isoform X1 [KO:K08044] [EC:4.6.1.1]
103588664  ADCY5; adenylate cyclase type 5 [KO:K08045] [EC:4.6.1.1]
103588863  ADCY6; adenylate cyclase type 6 [KO:K08046] [EC:4.6.1.1]
103594947  ADCY7; adenylate cyclase type 7 [KO:K08047] [EC:4.6.1.1]
103583204  adenylate cyclase type 7-like [KO:K08047] [EC:4.6.1.1]
103591872  ADCY8; adenylate cyclase type 8 [KO:K08048] [EC:4.6.1.1]
103591384  ADCY9; adenylate cyclase type 9 [KO:K08049] [EC:4.6.1.1]
103589593  PRKACB; cAMP-dependent protein kinase catalytic subunit beta isoform X1 [KO:K04345] [EC:2.7.11.11]
103585135  PRKACA; cAMP-dependent protein kinase catalytic subunit alpha isoform X1 [KO:K04345] [EC:2.7.11.11]
103599715  GNB1; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 [KO:K04536]
103596930  GNB2; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 [KO:K04537]
103586407  GNB3; guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3 isoform X1 [KO:K07825]
103586779  GNB4; guanine nucleotide-binding protein subunit beta-4 [KO:K04538]
103601724  GNB5; guanine nucleotide-binding protein subunit beta-5 [KO:K04539]
103591088  GNG3; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3 [KO:K04540]
103592984  GNG8; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-8 isoform X1 [KO:K04544]
103589599  GNG11; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11 [KO:K04546]
103588774  GNG13; guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-13 [KO:K04547]
103589588  GNGT1; guanine nucleotide-binding protein G(T) subunit gamma-T1 isoform X1 [KO:K04548]
103594181  COL4A1; collagen alpha-1(IV) chain [KO:K06237]
103605497  COL4A2; collagen alpha-2(IV) chain [KO:K06237]
103598440  COL4A6; collagen alpha-6(IV) chain isoform X1 [KO:K06237]
103586159  COL4A3; collagen alpha-3(IV) chain [KO:K06237]
103586162  COL4A4; collagen alpha-4(IV) chain [KO:K06237]
103607716  collagen alpha-5(IV) chain [KO:K06237]
103605977  LAMA1; LOW QUALITY PROTEIN: laminin subunit alpha-1 [KO:K05637]
103587254  LAMA2; laminin subunit alpha-2 [KO:K05637]
103588765  LAMA5; LOW QUALITY PROTEIN: laminin subunit alpha-5 [KO:K06240]
103593625  LAMA3; laminin subunit alpha-3 [KO:K06240]
103599731  LAMA4; laminin subunit alpha-4 [KO:K06241]
103591725  LOW QUALITY PROTEIN: laminin subunit beta-1-like [KO:K05636]
103586174  LAMB1; laminin subunit beta-1 isoform X1 [KO:K05636]
103584940  LAMB2; laminin subunit beta-2 [KO:K06243]
103598268  LAMB3; laminin subunit beta-3 [KO:K06244]
103586173  LAMB4; laminin subunit beta-4 [KO:K06245]
103586651  LAMC1; laminin subunit gamma-1 [KO:K05635]
103586645  LAMC2; laminin subunit gamma-2 [KO:K06246]
103599113  LAMC3; laminin subunit gamma-3 [KO:K06247]
103595436  FN1; fibronectin [KO:K05717]
103591124  ITGA2; integrin alpha-2 [KO:K06481]
103606240  ITGA2B; integrin alpha-IIb [KO:K06476]
103589765  ITGA3; integrin alpha-3 isoform X1 [KO:K06482]
103600955  integrin alpha-6 [KO:K06485]
103604851  ITGAV; integrin alpha-V [KO:K06487]
103606818  integrin alpha-V-like [KO:K06487]
103601646  ITGB1; integrin beta-1 [KO:K05719]
103587023  PTK2; focal adhesion kinase 1 isoform X1 [KO:K05725] [EC:2.7.10.2]
103586572  PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
103586784  PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
103587883  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [KO:K00922] [EC:2.7.1.153]
103585463  PIK3R3; LOW QUALITY PROTEIN: phosphatidylinositol 3-kinase regulatory subunit gamma [KO:K02649]
103593683  PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
103608454  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
103592918  PTEN; phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
103592527  NKX3-1; homeobox protein Nkx-3.1 [KO:K09348]
103596384  AKT1; RAC-alpha serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
103590279  AKT3; RAC-gamma serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
103598325  AKT2; RAC-beta serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
103605698  RAC-gamma serine/threonine-protein kinase-like [KO:K04456] [EC:2.7.11.1]
103588798  CHUK; inhibitor of nuclear factor kappa-B kinase subunit alpha [KO:K04467] [EC:2.7.11.10]
103589266  IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta [KO:K07209] [EC:2.7.11.10]
103604367  IKBKG; NF-kappa-B essential modulator [KO:K07210]
103591436  NFKBIA; LOW QUALITY PROTEIN: NF-kappa-B inhibitor alpha [KO:K04734]
103597025  NFKB1; nuclear factor NF-kappa-B p105 subunit [KO:K02580]
103588100  NFKB2; nuclear factor NF-kappa-B p100 subunit isoform X1 [KO:K04469]
103595334  RELA; transcription factor p65 [KO:K04735]
103592767  PTGS2; prostaglandin G/H synthase 2 [KO:K11987] [EC:1.14.99.1]
103604568  NOS2; LOW QUALITY PROTEIN: nitric oxide synthase, inducible [KO:K13241] [EC:1.14.13.39]
103606686  BCL2; apoptosis regulator Bcl-2 [KO:K02161]
103596078  BIRC2; baculoviral IAP repeat-containing protein 2 [KO:K16060]
103596079  BIRC3; baculoviral IAP repeat-containing protein 3 [KO:K16060]
103610749  E3 ubiquitin-protein ligase XIAP-like [KO:K04725] [EC:2.3.2.27]
103608053  XIAP; E3 ubiquitin-protein ligase XIAP [KO:K04725] [EC:2.3.2.27]
103596970  BIRC7; baculoviral IAP repeat-containing protein 7 [KO:K16061]
103594063  BCL2L1; bcl-2-like protein 1 isoform X1 [KO:K04570]
103587301  TRAF1; TNF receptor-associated factor 1 [KO:K03172]
103610047  TNF receptor-associated factor 2 [KO:K03173] [EC:2.3.2.27]
103610988  TRAF2; TNF receptor-associated factor 2 [KO:K03173] [EC:2.3.2.27]
103609553  TRAF3; TNF receptor-associated factor 3 [KO:K03174]
103598599  TRAF4; TNF receptor-associated factor 4 [KO:K09848]
103599657  TRAF5; TNF receptor-associated factor 5 [KO:K09849]
103601167  TRAF6; TNF receptor-associated factor 6 [KO:K03175] [EC:2.3.2.27]
103601062  MTOR; serine/threonine-protein kinase mTOR isoform X1 [KO:K07203] [EC:2.7.11.1]
103595380  RPS6KB1; ribosomal protein S6 kinase beta-1 isoform X1 [KO:K04688] [EC:2.7.11.1]
103589982  RPS6KB2; ribosomal protein S6 kinase beta-2 isoform X1 [KO:K04688] [EC:2.7.11.1]
103586204  BAD; bcl2 antagonist of cell death [KO:K02158]
103597250  FOXO1; LOW QUALITY PROTEIN: forkhead box protein O1 [KO:K07201]
103601365  MDM2; E3 ubiquitin-protein ligase Mdm2 isoform X1 [KO:K06643] [EC:2.3.2.27]
103591400  TP53; cellular tumor antigen p53 [KO:K04451]
103592695  CDKN1B; cyclin-dependent kinase inhibitor 1B [KO:K06624]
103607313  CDKN1A; cyclin-dependent kinase inhibitor 1 [KO:K06625]
103591928  BCR; breakpoint cluster region protein isoform X1 [KO:K08878] [EC:2.7.11.1]
103605912  ABL1; tyrosine-protein kinase ABL1 [KO:K06619] [EC:2.7.10.2]
103592708  CRKL; crk-like protein [KO:K04438]
103608491  CRK; adapter molecule crk isoform X1 [KO:K04438]
103592896  CBL; E3 ubiquitin-protein ligase CBL [KO:K04707] [EC:2.3.2.27]
103587552  LOW QUALITY PROTEIN: E3 ubiquitin-protein ligase CBL-like [KO:K04707] [EC:2.3.2.27]
103595355  STAT5A; signal transducer and activator of transcription 5A [KO:K11223]
103595352  LOW QUALITY PROTEIN: signal transducer and activator of transcription 5B-like [KO:K11224]
103582921  serine/threonine-protein kinase pim-1 [KO:K04702] [EC:2.7.11.1]
103587033  PIM1; serine/threonine-protein kinase pim-1 [KO:K04702] [EC:2.7.11.1]
103589442  PIM2; serine/threonine-protein kinase pim-2 [KO:K08806] [EC:2.7.11.1]
103598676  KNG1; kininogen-1 isoform X1 [KO:K03898]
103608229  EDN1; endothelin-1 [KO:K16366]
103605884  BDKRB1; B1 bradykinin receptor [KO:K03915]
103610748  BDKRB2; B2 bradykinin receptor [KO:K03916]
103583369  EDNRA; endothelin-1 receptor [KO:K04197]
103590322  EDNRB; LOW QUALITY PROTEIN: endothelin B receptor [KO:K04198]
103587098  GNAQ; guanine nucleotide-binding protein G(q) subunit alpha [KO:K04634]
103604359  guanine nucleotide-binding protein subunit alpha-11 [KO:K04635]
103588545  1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2-like [KO:K05858] [EC:3.1.4.11]
103596484  PLCB1; LOW QUALITY PROTEIN: 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 [KO:K05858] [EC:3.1.4.11]
103591300  1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 isoform X1 [KO:K05858] [EC:3.1.4.11]
103586228  PLCB3; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 [KO:K05858] [EC:3.1.4.11]
103606378  PLCB4; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 [KO:K05858] [EC:3.1.4.11]
103599847  PRKCA; protein kinase C alpha type [KO:K02677] [EC:2.7.11.13]
103592574  PRKCB; protein kinase C beta type isoform X1 [KO:K19662] [EC:2.7.11.13]
103583388  protein kinase C gamma type [KO:K19663] [EC:2.7.11.13]
103599669  PRKCG; protein kinase C gamma type [KO:K19663] [EC:2.7.11.13]
103593609  IL2; interleukin-2 [KO:K05429]
103589624  IL4; interleukin-4 [KO:K05430]
103589615  IL5; interleukin-5 isoform X1 [KO:K05428]
103585928  IL6; interleukin-6 [KO:K05405]
103593320  IL7; interleukin-7 isoform X1 [KO:K05431]
103605130  IL12A; LOW QUALITY PROTEIN: interleukin-12 subunit alpha [KO:K05406]
103607235  IL12B; interleukin-12 subunit beta [KO:K05425]
103589625  IL13; interleukin-13 [KO:K05435]
103607305  IL15; interleukin-15 [KO:K05433]
103594015  IL23A; interleukin-23 subunit alpha [KO:K05426]
103596935  EPO; erythropoietin isoform X1 [KO:K05437]
103598039  interferon alpha-4-like [KO:K05414]
103598040  interferon alpha-10-like [KO:K05414]
103598043  interferon alpha-10-like [KO:K05414]
103598044  interferon alpha-3-like [KO:K05414]
103609732  interferon gamma-like [KO:K04687]
103605815  interferon gamma-like [KO:K04687]
103607987  interleukin-2 receptor subunit alpha-like [KO:K05068]
103606392  IL2RB; interleukin-2 receptor subunit beta [KO:K05069]
103586318  IL2RG; cytokine receptor common subunit gamma [KO:K05070]
103586816  IL3RA; interleukin-3 receptor subunit alpha [KO:K04737]
103585606  IL4R; interleukin-4 receptor subunit alpha [KO:K05071]
103602076  CSF2RB; cytokine receptor common subunit beta [KO:K04738]
103599272  IL5RA; interleukin-5 receptor subunit alpha [KO:K05067]
103608410  IL6R; interleukin-6 receptor subunit alpha [KO:K05055]
103588371  IL6ST; interleukin-6 receptor subunit beta isoform X1 [KO:K05060]
103592180  IL7R; interleukin-7 receptor subunit alpha [KO:K05072]
103593685  IL12RB1; LOW QUALITY PROTEIN: interleukin-12 receptor subunit beta-1 [KO:K05063]
103592008  interleukin-12 receptor subunit beta-2-like [KO:K05064]
103587832  IL13RA1; interleukin-13 receptor subunit alpha-1 isoform X1 [KO:K05076]
103587845  IL15RA; interleukin-15 receptor subunit alpha [KO:K05074]
103600737  IL23R; interleukin-23 receptor [KO:K05065]
103591359  EPOR; erythropoietin receptor [KO:K05079]
103585996  IFNAR1; interferon alpha/beta receptor 1 isoform X1 [KO:K05130]
103585997  IFNAR2; interferon alpha/beta receptor 2 [KO:K05131]
103591435  IFNGR1; interferon gamma receptor 1 [KO:K05132]
103585995  IFNGR2; interferon gamma receptor 2 [KO:K05133]
103587993  EML4; echinoderm microtubule-associated protein-like 4 [KO:K15420]
103585431  ALK; ALK tyrosine kinase receptor [KO:K05119] [EC:2.7.10.1]
103597262  RASGRP1; RAS guanyl-releasing protein 1 [KO:K04350]
103590620  RASGRP2; RAS guanyl-releasing protein 2 [KO:K12361]
103597236  ras guanyl-releasing protein 3-like [KO:K12362]
103586838  ras guanyl-releasing protein 3 [KO:K12362]
103591480  RASGRP4; RAS guanyl-releasing protein 4 [KO:K12363]
103591505  JAK1; tyrosine-protein kinase JAK1 [KO:K11217] [EC:2.7.10.2]
103594579  JAK2; tyrosine-protein kinase JAK2 [KO:K04447] [EC:2.7.10.2]
103593677  JAK3; tyrosine-protein kinase JAK3 [KO:K11218] [EC:2.7.10.2]
103595356  signal transducer and activator of transcription 3-like [KO:K04692]
103588074  STAT1; signal transducer and activator of transcription 1-alpha/beta [KO:K11220]
103594016  STAT2; signal transducer and activator of transcription 2 [KO:K11221]
103588073  STAT4; signal transducer and activator of transcription 4 [KO:K11222]
103596102  STAT6; signal transducer and activator of transcription 6 [KO:K11225]
103585760  VEGFA; LOW QUALITY PROTEIN: vascular endothelial growth factor A [KO:K05448]
103586230  VEGFB; vascular endothelial growth factor B [KO:K16858]
103586269  PGF; placenta growth factor isoform X1 [KO:K16859]
103604028  FIGF; vascular endothelial growth factor D [KO:K05449]
103597355  VEGFC; vascular endothelial growth factor C [KO:K05449]
103603040  TGFA; protransforming growth factor alpha isoform X1 [KO:K08774]
103588497  EGF; pro-epidermal growth factor isoform X1 [KO:K04357]
103595295  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]
103604776  epidermal growth factor receptor-like [KO:K04361] [EC:2.7.10.1]
103605206  ERBB2; receptor tyrosine-protein kinase erbB-2 [KO:K05083] [EC:2.7.10.1]
103595105  PDGFA; platelet-derived growth factor subunit A isoform X1 [KO:K04359]
103600468  PDGFB; platelet-derived growth factor subunit B isoform X1 [KO:K17386]
103589787  PDGFRA; platelet-derived growth factor receptor alpha [KO:K04363] [EC:2.7.10.1]
103585042  PDGFRB; platelet-derived growth factor receptor beta isoform X1 [KO:K05089] [EC:2.7.10.1]
103601524  IGF1; insulin-like growth factor I isoform X1 [KO:K05459]
103595283  IGF2; insulin-like growth factor II [KO:K13769]
103595208  IGF1R; insulin-like growth factor 1 receptor isoform X1 [KO:K05087] [EC:2.7.10.1]
103587175  KITLG; kit ligand isoform X1 [KO:K05461]
103595701  KIT; mast/stem cell growth factor receptor Kit isoform X1 [KO:K05091] [EC:2.7.10.1]
103592617  fms-related tyrosine kinase 3 ligand-like [KO:K05454]
103592618  LOW QUALITY PROTEIN: fms-related tyrosine kinase 3 ligand-like [KO:K05454]
103610970  receptor-type tyrosine-protein kinase FLT3-like [KO:K05092] [EC:2.7.10.1]
103603769  FLT3; receptor-type tyrosine-protein kinase FLT3 [KO:K05092] [EC:2.7.10.1]
103587362  HGF; hepatocyte growth factor isoform X1 [KO:K05460]
103597189  MET; hepatocyte growth factor receptor [KO:K05099] [EC:2.7.10.1]
103590682  FGF1; fibroblast growth factor 1 isoform X1 [KO:K18496]
103594351  FGF18; fibroblast growth factor 18 [KO:K04358]
103588673  FGF7; fibroblast growth factor 7 [KO:K04358]
103588746  FGF20; fibroblast growth factor 20 [KO:K04358]
103609408  FGF6; fibroblast growth factor 6 [KO:K04358]
103602136  FGF10; fibroblast growth factor 10 isoform X1 [KO:K04358]
103610085  FGF22; fibroblast growth factor 22 [KO:K04358]
103595413  FGF8; fibroblast growth factor 8 [KO:K04358]
103597068  FGF16; fibroblast growth factor 16 [KO:K04358]
103604998  fibroblast growth factor 2-like [KO:K04358]
103604999  FGF3; fibroblast growth factor 3 [KO:K04358]
103591744  FGF9; fibroblast growth factor 9 [KO:K04358]
103586304  FGF5; fibroblast growth factor 5 isoform X1 [KO:K04358]
103593962  FGF17; fibroblast growth factor 17 [KO:K04358]
103604091  FGF19; fibroblast growth factor 19 [KO:K22603]
103587751  FGF21; fibroblast growth factor 21 [KO:K22429]
103603960  FGF23; fibroblast growth factor 23 [KO:K22428]
103598755  FGFR1; fibroblast growth factor receptor 1 [KO:K04362] [EC:2.7.10.1]
103601242  FGFR2; fibroblast growth factor receptor 2 isoform X1 [KO:K05093] [EC:2.7.10.1]
103587648  FGFR3; fibroblast growth factor receptor 3 [KO:K05094] [EC:2.7.10.1]
103593101  FGFR4; fibroblast growth factor receptor 4 isoform X1 [KO:K05095] [EC:2.7.10.1]
103585172  GRB2; growth factor receptor-bound protein 2 [KO:K04364]
103589434  SOS2; son of sevenless homolog 2 isoform X1 [KO:K03099]
103610513  HRAS; GTPase HRas isoform X1 [KO:K02833]
103599501  KRAS; GTPase KRas [KO:K07827]
103589329  NRAS; GTPase NRas [KO:K07828]
103594183  ARAF; serine/threonine-protein kinase A-Raf [KO:K08845] [EC:2.7.11.1]
103596180  BRAF; serine/threonine-protein kinase B-raf isoform X1 [KO:K04365] [EC:2.7.11.1]
103590618  RAF1; RAF proto-oncogene serine/threonine-protein kinase [KO:K04366] [EC:2.7.11.1]
103596129  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
103600170  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 isoform X1 [KO:K04369] [EC:2.7.12.2]
103592192  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
103600324  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
103592390  JUN; transcription factor AP-1 [KO:K04448]
103605891  FOS; proto-oncogene c-Fos [KO:K04379]
103585512  ETS1; protein C-ets-1 [KO:K02678]
103610223  interstitial collagenase [KO:K01388] [EC:3.4.24.7]
103610004  72 kDa type IV collagenase [KO:K01398] [EC:3.4.24.24]
103610353  72 kDa type IV collagenase-like [KO:K01398] [EC:3.4.24.24]
103589573  MMP9; matrix metalloproteinase-9 [KO:K01403] [EC:3.4.24.35]
103591379  CXCL8; interleukin-8 [KO:K10030]
103609174  CDK4; cyclin-dependent kinase 4 [KO:K02089] [EC:2.7.11.22]
103588451  RPS6KA5; ribosomal protein S6 kinase alpha-5 [KO:K04445] [EC:2.7.11.1]
103605929  RET; proto-oncogene tyrosine-protein kinase receptor Ret [KO:K05126] [EC:2.7.10.1]
103598782  transcription factor Maf-like [KO:K09288]
103606499  CCDC6; coiled-coil domain-containing protein 6 [KO:K09288]
103588322  NCOA4; nuclear receptor coactivator 4 isoform X1 [KO:K09289]
103588563  NTRK1; high affinity nerve growth factor receptor isoform X1 [KO:K03176] [EC:2.7.10.1]
103607884  TPM3; tropomyosin alpha-3 chain isoform X1 [KO:K09290]
103590576  TPR; nucleoprotein TPR [KO:K09291]
103608170  protein TFG-like [KO:K09292]
103593703  RASSF1; ras association domain-containing protein 1 isoform X1 [KO:K09850]
103590777  RASSF5; ras association domain-containing protein 5 [KO:K08015]
103604429  STK4; serine/threonine-protein kinase 4 isoform X1 [KO:K04411]
103604022  DAPK1; death-associated protein kinase 1 [KO:K08803] [EC:2.7.11.1]
103606999  DAPK3; death-associated protein kinase 3 [KO:K08803] [EC:2.7.11.1]
103587417  DAPK2; death-associated protein kinase 2 [KO:K08803] [EC:2.7.11.1]
103606318  PLCG1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X1 [KO:K01116] [EC:3.1.4.11]
103591521  PLCG2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 [KO:K05859] [EC:3.1.4.11]
103594186  ELK1; ETS domain-containing protein Elk-1 isoform X1 [KO:K04375]
103601309  calmodulin-like protein 3 [KO:K02183]
103601310  CALML5; calmodulin-like protein 5 [KO:K02183]
103588449  CALM1; calmodulin [KO:K02183]
103601992  calmodulin-like [KO:K02183]
103591330  CALML4; calmodulin-like protein 4 isoform X1 [KO:K02183]
103592983  CALM3; LOW QUALITY PROTEIN: calmodulin [KO:K02183]
103599723  CALML6; LOW QUALITY PROTEIN: calmodulin-like protein 6 [KO:K02183]
103595135  CAMK2G; calcium/calmodulin-dependent protein kinase type II subunit gamma [KO:K04515] [EC:2.7.11.17]
103583890  CAMK2D; calcium/calmodulin-dependent protein kinase type II subunit delta isoform X1 [KO:K04515] [EC:2.7.11.17]
103585039  CAMK2A; calcium/calmodulin-dependent protein kinase type II subunit alpha [KO:K04515] [EC:2.7.11.17]
103592962  CAMK2B; calcium/calmodulin-dependent protein kinase type II subunit beta isoform X1 [KO:K04515] [EC:2.7.11.17]
103581819  ral-GDS-related protein-like [KO:K08732]
103582164  RALGDS; ral guanine nucleotide dissociation stimulator [KO:K08732]
103596226  ras-related protein Ral-A-like [KO:K07834]
103602525  RALB; ras-related protein Ral-B [KO:K07835]
103590485  RALBP1; ralA-binding protein 1 [KO:K08773]
103598977  cell division control protein 42 homolog isoform X1 [KO:K04393]
103594082  RAC1; ras-related C3 botulinum toxin substrate 1 [KO:K04392]
103606391  RAC2; ras-related C3 botulinum toxin substrate 2 [KO:K07860]
103593345  RAC3; ras-related C3 botulinum toxin substrate 3 [KO:K07861]
103588418  PLD2; phospholipase D2 [KO:K01115] [EC:3.1.4.4]
103609225  phospholipase D1 [KO:K01115] [EC:3.1.4.4]
103582610  mitogen-activated protein kinase 9-like isoform X1 [KO:K04440] [EC:2.7.11.24]
103603521  mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]
103585627  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]
103606635  MAPK9; mitogen-activated protein kinase 9 isoform X1 [KO:K04440] [EC:2.7.11.24]
103595759  PAX8; paired box protein Pax-8 [KO:K09293]
103590613  PPARG; peroxisome proliferator-activated receptor gamma [KO:K08530]
103591675  RXRA; retinoic acid receptor RXR-alpha [KO:K08524]
103597936  RXRB; retinoic acid receptor RXR-beta isoform X1 [KO:K08525]
103607349  RXRG; retinoic acid receptor RXR-gamma [KO:K08526]
103596636  RARB; retinoic acid receptor beta isoform X1 [KO:K08528]
103585324  ESR2; estrogen receptor beta [KO:K08551]
103588816  NCOA1; nuclear receptor coactivator 1 isoform X1 [KO:K09101] [EC:2.3.1.48]
103592163  NCOA3; nuclear receptor coactivator 3 [KO:K11256] [EC:2.3.1.48]
103592813  SP1; transcription factor Sp1 [KO:K04684]
103590226  PPARD; peroxisome proliferator-activated receptor delta isoform X1 [KO:K04504]
103589174  JUP; junction plakoglobin [KO:K10056]
103594594  ZBTB16; zinc finger and BTB domain-containing protein 16 [KO:K10055]
103607734  RARA; retinoic acid receptor alpha isoform X1 [KO:K08527]
103602373  CCNA1; cyclin-A1 [KO:K06627]
103608004  CCNA2; cyclin-A2 [KO:K06627]
103588070  PML; protein PML isoform X1 [KO:K10054] [EC:2.3.2.-]
103586963  RUNX1; runt-related transcription factor 1 isoform X1 [KO:K08367]
103594598  RUNX1T1; protein CBFA2T1 [KO:K10053]
103592089  SPI1; transcription factor PU.1 isoform X1 [KO:K09438]
103598950  CEBPA; CCAAT/enhancer-binding protein alpha [KO:K09055]
103586806  CSF2RA; granulocyte-macrophage colony-stimulating factor receptor subunit alpha [KO:K05066]
103606067  granulocyte colony-stimulating factor receptor-like [KO:K05061]
103606070  CSF3R; granulocyte colony-stimulating factor receptor [KO:K05061]
103585043  CSF1R; macrophage colony-stimulating factor 1 receptor [KO:K05090] [EC:2.7.10.1]
103608706  CDKN2A; cyclin-dependent kinase inhibitor 2A isoform X1 [KO:K06621]
103586861  E2F1; transcription factor E2F1 [KO:K17454]
103590624  E2F2; transcription factor E2F2 [KO:K09389]
103590253  E2F3; transcription factor E2F3 [KO:K06620]
103598878  MAX; protein max isoform X1 [KO:K04453]
103581851  zinc finger and BTB domain-containing protein 17 isoform X1 [KO:K10500]
103604259  zinc finger and BTB domain-containing protein 17 isoform X1 [KO:K10500]
103608705  CDKN2B; cyclin-dependent kinase 4 inhibitor B [KO:K04685]
103590136  CDK6; cyclin-dependent kinase 6 [KO:K02091] [EC:2.7.11.22]
103603964  CCND2; G1/S-specific cyclin-D2 [KO:K10151]
103587459  CCND3; G1/S-specific cyclin-D3 isoform X1 [KO:K10152]
103588377  CKS2; cyclin-dependent kinases regulatory subunit 2 [KO:K02219]
103608190  CKS1B; cyclin-dependent kinases regulatory subunit 1 [KO:K02219]
103583634  S-phase kinase-associated protein 1-like [KO:K03094]
103605443  LOW QUALITY PROTEIN: S-phase kinase-associated protein 1-like [KO:K03094]
103592397  SKP1; S-phase kinase-associated protein 1 [KO:K03094]
103592393  CUL1; cullin-1 [KO:K03347]
103585666  RBX1; E3 ubiquitin-protein ligase RBX1 [KO:K03868] [EC:2.3.2.32]
103597559  SKP2; S-phase kinase-associated protein 2 isoform X1 [KO:K03875]
103610793  CDK2; cyclin-dependent kinase 2 isoform X1 [KO:K02206] [EC:2.7.11.22]
103602907  CCNE2; G1/S-specific cyclin-E2 [KO:K06626]
103603724  CCNE1; G1/S-specific cyclin-E1 [KO:K06626]
103593663  RB1; retinoblastoma-associated protein [KO:K06618]
103588373  GADD45G; growth arrest and DNA damage-inducible protein GADD45 gamma [KO:K04402]
103597016  GADD45B; growth arrest and DNA damage-inducible protein GADD45 beta [KO:K04402]
103592005  GADD45A; growth arrest and DNA damage-inducible protein GADD45 alpha [KO:K04402]
103587762  BAX; apoptosis regulator BAX isoform X1 [KO:K02159]
103599851  BAK1; bcl-2 homologous antagonist/killer [KO:K14021]
103592096  DDB2; DNA damage-binding protein 2 [KO:K10140]
103598508  POLK; DNA polymerase kappa [KO:K03511] [EC:2.7.7.7]
103586074  MITF; microphthalmia-associated transcription factor isoform X1 [KO:K09455]
103599185  transforming growth factor beta-1 [KO:K13375]
103599191  transforming growth factor beta-1-like [KO:K13375]
103604625  TGFB2; transforming growth factor beta-2 isoform X1 [KO:K13376]
103585960  TGFB3; transforming growth factor beta-3 [KO:K13377]
103587310  TGFBR1; TGF-beta receptor type-1 [KO:K04674] [EC:2.7.11.30]
103591905  TGFBR2; TGF-beta receptor type-2 isoform X1 [KO:K04388] [EC:2.7.11.30]
103595293  SMAD2; mothers against decapentaplegic homolog 2 [KO:K04500]
103590291  SMAD3; mothers against decapentaplegic homolog 3 isoform X1 [KO:K23605]
103600109  SMAD4; mothers against decapentaplegic homolog 4 isoform X1 [KO:K04501]
103587514  MECOM; MDS1 and EVI1 complex locus protein EVI1 isoform X1 [KO:K04462] [EC:2.1.1.367]
103604545  CTBP2; C-terminal-binding protein 2 isoform X1 [KO:K04496] [EC:1.1.1.428]
103587720  CTBP1; C-terminal-binding protein 1 isoform X1 [KO:K04496] [EC:1.1.1.428]
103594928  HDAC1; histone deacetylase 1 [KO:K06067] [EC:3.5.1.98]
103604993  HDAC2; histone deacetylase 2 [KO:K06067] [EC:3.5.1.98]
103605319  MLH1; DNA mismatch repair protein Mlh1 isoform X1 [KO:K08734]
103601778  MSH2; DNA mismatch repair protein Msh2 [KO:K08735]
103585604  MSH3; DNA mismatch repair protein Msh3 [KO:K08736]
103589628  MSH6; DNA mismatch repair protein Msh6 [KO:K08737]
103595849  BRCA2; breast cancer type 2 susceptibility protein [KO:K08775]
103588531  RAD51; DNA repair protein RAD51 homolog 1 isoform X1 [KO:K04482]
103605950  FASLG; tumor necrosis factor ligand superfamily member 6 [KO:K04389]
103607184  FAS; tumor necrosis factor receptor superfamily member 6 [KO:K04390]
103605154  FADD; FAS-associated death domain protein [KO:K02373]
103597790  CASP8; caspase-8 [KO:K04398] [EC:3.4.22.61]
103594881  BID; BH3-interacting domain death agonist [KO:K04726]
103607162  PMAIP1; phorbol-12-myristate-13-acetate-induced protein 1 [KO:K10131]
103599629  BBC3; bcl-2-binding component 3 [KO:K10132]
103610678  cytochrome c, somatic [KO:K08738]
103590229  cytochrome c, somatic-like [KO:K08738]
103590490  APAF1; apoptotic protease-activating factor 1 [KO:K02084]
103589128  CASP7; caspase-7 isoform X1 [KO:K04397] [EC:3.4.22.60]
103581203  KEAP1; kelch-like ECH-associated protein 1 [KO:K10456]
103591057  NFE2L2; nuclear factor erythroid 2-related factor 2 [KO:K05638]
103582640  heme oxygenase 1-like [KO:K00510] [EC:1.14.14.18]
103605520  HMOX1; heme oxygenase 1 [KO:K00510] [EC:1.14.14.18]
103586589  NQO1; NAD(P)H dehydrogenase [quinone] 1 [KO:K00355] [EC:1.6.5.2]
103609025  glutathione S-transferase A2 isoform X1 [KO:K00799] [EC:2.5.1.18]
103609252  GSTA4; glutathione S-transferase A4 isoform X1 [KO:K00799] [EC:2.5.1.18]
103595313  MGST3; microsomal glutathione S-transferase 3 [KO:K00799] [EC:2.5.1.18]
103601973  MGST1; microsomal glutathione S-transferase 1 [KO:K00799] [EC:2.5.1.18]
103583638  uncharacterized protein LOC103583638 [KO:K00799] [EC:2.5.1.18]
103605422  GSTO1; glutathione S-transferase omega-1 [KO:K00799] [EC:2.5.1.18]
103605424  glutathione S-transferase omega-2-like [KO:K00799] [EC:2.5.1.18]
103585612  glutathione S-transferase Mu 1 [KO:K00799] [EC:2.5.1.18]
103585621  glutathione S-transferase Mu 1-like [KO:K00799] [EC:2.5.1.18]
103585630  GSTM3; glutathione S-transferase Mu 3 [KO:K00799] [EC:2.5.1.18]
103587154  glutathione S-transferase theta-2B-like isoform X1 [KO:K00799] [EC:2.5.1.18]
103587155  glutathione S-transferase theta-4 [KO:K00799] [EC:2.5.1.18]
103587156  glutathione S-transferase theta-1-like [KO:K00799] [EC:2.5.1.18]
103587157  glutathione S-transferase theta-1 isoform X1 [KO:K00799] [EC:2.5.1.18]
103587634  MGST2; microsomal glutathione S-transferase 2 [KO:K00799] [EC:2.5.1.18]
103593805  GSTO2; glutathione S-transferase omega-2 [KO:K00799] [EC:2.5.1.18]
103597997  GSTP1; glutathione S-transferase P [KO:K23790] [EC:2.5.1.18]
103588576  TXNRD1; thioredoxin reductase 1, cytoplasmic [KO:K22182] [EC:1.8.1.9]
103581816  thioredoxin reductase 3 [KO:K22182] [EC:1.8.1.9]
103582087  thioredoxin reductase 2, mitochondrial-like [KO:K22182] [EC:1.8.1.9]
103608524  TXNRD2; thioredoxin reductase 2, mitochondrial [KO:K22182] [EC:1.8.1.9]
103607322  VHL; von Hippel-Lindau disease tumor suppressor [KO:K03871]
103595473  TCEB1; transcription elongation factor B polypeptide 1 [KO:K03872]
103587032  transcription elongation factor B polypeptide 1-like [KO:K03872]
103585383  TCEB2; transcription elongation factor B polypeptide 2 [KO:K03873]
103604482  CUL2; cullin-2 [KO:K03870]
103603543  EGLN2; egl nine homolog 2 isoform X1 [KO:K09592] [EC:1.14.11.29]
103607201  EGLN3; egl nine homolog 3 [KO:K09592] [EC:1.14.11.29]
103592505  FH; fumarate hydratase, mitochondrial [KO:K01679] [EC:4.2.1.2]
103585213  HIF1A; hypoxia-inducible factor 1-alpha [KO:K08268]
103596730  EPAS1; endothelial PAS domain-containing protein 1 [KO:K09095]
103600278  ARNT; aryl hydrocarbon receptor nuclear translocator isoform X1 [KO:K09097]
103603083  aryl hydrocarbon receptor nuclear translocator 2-like [KO:K15589]
103595030  CREBBP; CREB-binding protein isoform X1 [KO:K04498] [EC:2.3.1.48]
103591893  EP300; histone acetyltransferase p300 [KO:K04498] [EC:2.3.1.48]
103590819  SLC2A1; solute carrier family 2, facilitated glucose transporter member 1 [KO:K07299]
103593080  JAG1; protein jagged-1 [KO:K06052]
103591759  JAG2; protein jagged-2 [KO:K21635]
103601359  DLL1; delta-like protein 1 [KO:K06051]
103588543  DLL4; delta-like protein 4 [KO:K06051]
103598510  DLL3; delta-like protein 3 [KO:K06051]
103581624  LOW QUALITY PROTEIN: neurogenic locus notch homolog protein 1-like [KO:K02599]
103590877  NOTCH1; neurogenic locus notch homolog protein 1 [KO:K02599]
103598534  LOW QUALITY PROTEIN: neurogenic locus notch homolog protein 2-like [KO:K20994]
103593431  NOTCH3; neurogenic locus notch homolog protein 3 [KO:K20995]
103603629  NOTCH4; LOW QUALITY PROTEIN: neurogenic locus notch homolog protein 4 [KO:K20996]
103600864  HES1; transcription factor HES-1 [KO:K06054]
103590327  HEY2; hairy/enhancer-of-split related with YRPW motif protein 2 [KO:K09091]
103585001  HEYL; hairy/enhancer-of-split related with YRPW motif-like protein [KO:K09091]
103600050  HEY1; hairy/enhancer-of-split related with YRPW motif protein 1 isoform X1 [KO:K09091]
103590309  FLT4; vascular endothelial growth factor receptor 3 [KO:K05097] [EC:2.7.10.1]
103582293  uncharacterized protein LOC103582293 [KO:K11988]
103586051  PTCH1; protein patched homolog 1 [KO:K06225]
103599009  SMO; smoothened homolog [KO:K06226]
103610768  KIF7; kinesin-like protein KIF7 isoform X1 [KO:K18806]
103584976  PLIN1; perilipin-1 [KO:K18806]
103588106  SUFU; suppressor of fused homolog isoform X1 [KO:K06229]
103594201  GLI1; zinc finger protein GLI1 [KO:K16797]
103592188  GLI2; zinc finger protein GLI2 [KO:K16798]
103601525  LOW QUALITY PROTEIN: transcriptional activator GLI3-like [KO:K06230]
103609832  BMP2; bone morphogenetic protein 2 [KO:K21283]
103588444  BMP4; bone morphogenetic protein 4 [KO:K04662]
103594689  HHIP; hedgehog-interacting protein isoform X1 [KO:K06231]
103609677  PTCH2; protein patched homolog 2 [KO:K11101]
103607832  protein patched homolog 2 [KO:K11101]
103597103  AR; androgen receptor [KO:K08557]
103588342  LOW QUALITY PROTEIN: heat shock protein HSP 90-beta-like [KO:K04079]
103595468  HSP90AA1; heat shock protein HSP 90-alpha [KO:K04079]
103590414  HSP90AB1; heat shock protein HSP 90-beta [KO:K04079]
103588567  HSP90B1; endoplasmin [KO:K09487]
Compound
C00027  Hydrogen peroxide
C00039  DNA
C00076  Calcium cation
C00122  Fumarate
C00149  (S)-Malate
C00165  Diacylglycerol
C00187  Cholesterol
C00280  Androstenedione
C00410  Progesterone
C00416  Phosphatidate
C00533  Nitric oxide
C00535  Testosterone
C00575  3',5'-Cyclic AMP
C00584  Prostaglandin E2
C00681  1-Acyl-sn-glycerol 3-phosphate
C00704  Superoxide
C00735  Cortisol
C00762  Cortisone
C00777  Retinoate
C00951  Estradiol-17beta
C01227  Dehydroepiandrosterone
C01245  D-myo-Inositol 1,4,5-trisphosphate
C01471  Acrolein
C03917  Dihydrotestosterone
C05981  Phosphatidylinositol-3,4,5-trisphosphate
C07653  Flutamide
C15493  9-cis-Retinoic acid
C16038  2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
C16844  Hydroxyl radical
C21641  Hydroperoxyl radical
C21642  4-Hydroxynonenal
Reference
  Authors
Weinberg RA.
  Title
The biology of cancer
  Journal
Garland Science, Taylor & Francis Group, LLC (2007)
Reference
PMID:10647931
  Authors
Hanahan D, Weinberg RA
  Title
The hallmarks of cancer.
  Journal
Cell 100:57-70 (2000)
DOI:10.1016/S0092-8674(00)81683-9
Reference
PMID:15000146
  Authors
Grady WM.
  Title
Genomic instability and colon cancer.
  Journal
Cancer Metastasis Rev 23:11-27 (2004)
DOI:10.1023/A:1025861527711
Reference
PMID:16555243
  Authors
Soreide K, Janssen EA, Soiland H, Korner H, Baak JP.
  Title
Microsatellite instability in colorectal cancer.
  Journal
Br J Surg 93:395-406 (2006)
DOI:10.1002/bjs.5328
Reference
PMID:11078609
  Authors
Anwar S, Hall C, White J, Deakin M, Farrell W, Elder JB.
  Title
Hereditary non-polyposis colorectal cancer: an updated review.
  Journal
Eur J Surg Oncol 26:635-45 (2000)
DOI:10.1053/ejso.2000.0974
Reference
PMID:16699851
  Authors
Takayama T, Miyanishi K, Hayashi T, Sato Y, Niitsu Y.
  Title
Colorectal cancer: genetics of development and metastasis.
  Journal
J Gastroenterol 41:185-92 (2006)
DOI:10.1007/s00535-006-1801-6
Reference
PMID:12621137
  Authors
Lynch HT, de la Chapelle A.
  Title
Hereditary colorectal cancer.
  Journal
N Engl J Med 348:919-32 (2003)
DOI:10.1056/NEJMra012242
Reference
PMID:12951588
  Authors
Rajagopalan H, Nowak MA, Vogelstein B, Lengauer C.
  Title
The significance of unstable chromosomes in colorectal cancer.
  Journal
Nat Rev Cancer 3:695-701 (2003)
DOI:10.1038/nrc1165
Reference
PMID:10505543
  Authors
Behrens J.
  Title
Cadherins and catenins: role in signal transduction and tumor progression.
  Journal
Cancer Metastasis Rev 18:15-30 (1999)
DOI:10.1023/A:1006200102166
Reference
PMID:16042571
  Authors
Behrens J.
  Title
The role of the Wnt signalling pathway in colorectal tumorigenesis.
  Journal
Biochem Soc Trans 33:672-5 (2005)
DOI:10.1042/BST0330672
Reference
PMID:15349822
  Authors
Behrens J, Lustig B.
  Title
The Wnt connection to tumorigenesis.
  Journal
Int J Dev Biol 48:477-87 (2004)
DOI:10.1387/ijdb.041815jb
Reference
PMID:9196022
  Authors
Polakis P.
  Title
The adenomatous polyposis coli (APC) tumor suppressor.
  Journal
Biochim Biophys Acta 1332:F127-47 (1997)
DOI:10.1016/S0304-419X(97)00008-5
Reference
PMID:12737309
  Authors
Janssen KP.
  Title
Murine models of colorectal cancer: studying the role of oncogenic K-ras.
  Journal
Cell Mol Life Sci 60:495-506 (2003)
DOI:10.1007/s000180300041
Reference
PMID:11459867
  Authors
Adjei AA.
  Title
Blocking oncogenic Ras signaling for cancer therapy.
  Journal
J Natl Cancer Inst 93:1062-74 (2001)
DOI:10.1093/jnci/93.14.1062
Reference
PMID:15573119
  Authors
Arakawa H.
  Title
Netrin-1 and its receptors in tumorigenesis.
  Journal
Nat Rev Cancer 4:978-87 (2004)
DOI:10.1038/nrc1504
Reference
PMID:15310786
  Authors
Mehlen P, Fearon ER.
  Title
Role of the dependence receptor DCC in colorectal cancer pathogenesis.
  Journal
J Clin Oncol 22:3420-8 (2004)
DOI:10.1200/JCO.2004.02.019
Reference
PMID:11223406
  Authors
Peltomaki P.
  Title
DNA mismatch repair and cancer.
  Journal
Mutat Res 488:77-85 (2001)
DOI:10.1016/S1383-5742(00)00058-2
Reference
PMID:15711891
  Authors
Li F, Cao Y, Townsend CM Jr, Ko TC.
  Title
TGF-beta signaling in colon cancer cells.
  Journal
World J Surg 29:306-11 (2005)
DOI:10.1007/s00268-004-7813-6
Reference
PMID:11170304
  Authors
Roman C, Saha D, Beauchamp R.
  Title
TGF-beta and colorectal carcinogenesis.
  Journal
Microsc Res Tech 52:450-7 (2001)
DOI:10.1002/1097-0029(20010215)52:4<450::AID-JEMT1030>3.0.CO;2-O
Reference
PMID:16326109
  Authors
Watson AJ.
  Title
An overview of apoptosis and the prevention of colorectal cancer.
  Journal
Crit Rev Oncol Hematol 57:107-21 (2006)
DOI:10.1016/j.critrevonc.2005.06.005
Reference
PMID:15479695
  Authors
Watson AJ.
  Title
Apoptosis and colorectal cancer.
  Journal
Gut 53:1701-9 (2004)
DOI:10.1136/gut.2004.052704
Reference
PMID:11477132
  Authors
Houlston RS.
  Title
What we could do now: molecular pathology of colorectal cancer.
  Journal
Mol Pathol 54:206-14 (2001)
DOI:10.1136/mp.54.4.206
Reference
  Authors
Von Hoff D, Evans D, Hruban R (ed).
  Title
Pancreatic cancer
  Journal
Jones and Bartlett publishers (2005)
Reference
  Authors
Niitsu Y, Yokota J (ed).
  Title
[Oncogenes and Tumor Suppressor Genes for Medical Oncologist] (In Japanese)
  Journal
Nankodo (1999)
Reference
PMID:12459728
  Authors
Bardeesy N, DePinho RA.
  Title
Pancreatic cancer biology and genetics.
  Journal
Nat Rev Cancer 2:897-909 (2002)
DOI:10.1038/nrc949
Reference
PMID:11407945
  Authors
Bardeesy N, Sharpless NE, DePinho RA, Merlino G.
  Title
The genetics of pancreatic adenocarcinoma: a roadmap for a mouse model.
  Journal
Semin Cancer Biol 11:201-18 (2001)
DOI:10.1006/scbi.2000.0371
Reference
PMID:12946833
  Authors
Cowgill SM, Muscarella P.
  Title
The genetics of pancreatic cancer.
  Journal
Am J Surg 186:279-86 (2003)
DOI:10.1016/S0002-9610(03)00226-5
Reference
PMID:16702400
  Authors
Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N, Depinho RA.
  Title
Genetics and biology of pancreatic ductal adenocarcinoma.
  Journal
Genes Dev 20:1218-49 (2006)
DOI:10.1101/gad.1415606
Reference
PMID:10740269
  Authors
Shields JM, Pruitt K, McFall A, Shaub A, Der CJ.
  Title
Understanding Ras: 'it ain't over 'til it's over'.
  Journal
Trends Cell Biol 10:147-54 (2000)
DOI:10.1016/S0962-8924(00)01740-2
Reference
PMID:12648469
  Authors
Holbro T, Civenni G, Hynes NE.
  Title
The ErbB receptors and their role in cancer progression.
  Journal
Exp Cell Res 284:99-110 (2003)
DOI:10.1016/S0014-4827(02)00099-X
Reference
PMID:14967450
  Authors
Marmor MD, Skaria KB, Yarden Y.
  Title
Signal transduction and oncogenesis by ErbB/HER receptors.
  Journal
Int J Radiat Oncol Biol Phys 58:903-13 (2004)
DOI:10.1016/j.ijrobp.2003.06.002
Reference
PMID:14586404
  Authors
DeArmond D, Brattain MG, Jessup JM, Kreisberg J, Malik S, Zhao S, Freeman JW.
  Title
Autocrine-mediated ErbB-2 kinase activation of STAT3 is required for growth factor independence of pancreatic cancer cell lines.
  Journal
Oncogene 22:7781-95 (2003)
DOI:10.1038/sj.onc.1206966
Reference
PMID:12545153
  Authors
Wei D, Le X, Zheng L, Wang L, Frey JA, Gao AC, Peng Z, Huang S, Xiong HQ, Abbruzzese JL, Xie K.
  Title
Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis.
  Journal
Oncogene 22:319-29 (2003)
DOI:10.1038/sj.onc.1206122
Reference
PMID:14580692
  Authors
Toyonaga T, Nakano K, Nagano M, Zhao G, Yamaguchi K, Kuroki S, Eguchi T, Chijiiwa K, Tsuneyoshi M, Tanaka M.
  Title
Blockade of constitutively activated Janus kinase/signal transducer and activator of transcription-3 pathway inhibits growth of human pancreatic cancer.
  Journal
Cancer Lett 201:107-16 (2003)
DOI:10.1016/S0304-3835(03)00482-8
Reference
PMID:12079267
  Authors
Schmid RM.
  Title
Genetic basis of pancreatic cancer.
  Journal
Best Pract Res Clin Gastroenterol 16:421-33 (2002)
DOI:10.1053/bega.2002.0316
Reference
PMID:15774796
  Authors
Elliott RL, Blobe GC.
  Title
Role of transforming growth factor Beta in human cancer.
  Journal
J Clin Oncol 23:2078-93 (2005)
DOI:10.1200/JCO.2005.02.047
Reference
PMID:15823750
  Authors
Rudkin TM, Foulkes WD.
  Title
BRCA2: breaks, mistakes and failed separations.
  Journal
Trends Mol Med 11:145-8 (2005)
DOI:10.1016/j.molmed.2005.02.003
Reference
PMID:11707511
  Authors
Venkitaraman AR.
  Title
Functions of BRCA1 and BRCA2 in the biological response to DNA damage.
  Journal
J Cell Sci 114:3591-8 (2001)
Reference
PMID:15639402
  Authors
Soni D, King JA, Kaye AH, Hovens CM.
  Title
Genetics of glioblastoma multiforme: mitogenic signaling and cell cycle pathways converge.
  Journal
J Clin Neurosci 12:1-5 (2005)
DOI:10.1016/j.jocn.2004.04.001
Reference
PMID:12154354
  Authors
Zhu Y, Parada LF.
  Title
The molecular and genetic basis of neurological tumours.
  Journal
Nat Rev Cancer 2:616-26 (2002)
DOI:10.1038/nrc866
Reference
PMID:11253051
  Authors
Holland EC.
  Title
Gliomagenesis: genetic alterations and mouse models.
  Journal
Nat Rev Genet 2:120-9 (2001)
DOI:10.1038/35052535
Reference
PMID:16700615
  Authors
Bansal K, Liang ML, Rutka JT.
  Title
Molecular biology of human gliomas.
  Journal
Technol Cancer Res Treat 5:185-94 (2006)
DOI:10.1177/153303460600500302
Reference
  Authors
Tabuchi K (ed).
  Title
[Gliomas: Research and therapy] (In Japanese)
  Journal
Springer-Verlag Tokyo (2006)
Reference
PMID:12762887
  Authors
Kapoor GS, O'Rourke DM.
  Title
Mitogenic signaling cascades in glial tumors.
  Journal
Neurosurgery 52:1425-34; discussion 1434-5 (2003)
DOI:10.1227/01.NEU.0000065135.28143.39
Reference
PMID:16095998
  Authors
Hulleman E, Helin K.
  Title
Molecular mechanisms in gliomagenesis.
  Journal
Adv Cancer Res 94:1-27 (2005)
DOI:10.1016/S0065-230X(05)94001-3
Reference
PMID:11057895
  Authors
Schlessinger J.
  Title
Cell signaling by receptor tyrosine kinases.
  Journal
Cell 103:211-25 (2000)
DOI:10.1016/S0092-8674(00)00114-8
Reference
PMID:9643506
  Authors
Ng HK, Lam PY.
  Title
The molecular genetics of central nervous system tumors.
  Journal
Pathology 30:196-202 (1998)
DOI:10.1080/00313029800169236
Reference
PMID:12084351
  Authors
Knobbe CB, Merlo A, Reifenberger G.
  Title
Pten signaling in gliomas.
  Journal
Neuro-oncol 4:196-211 (2002)
DOI:10.1093/neuonc/4.3.196
Reference
PMID:16557281
  Authors
Kondo T, Ezzat S, Asa SL.
  Title
Pathogenetic mechanisms in thyroid follicular-cell neoplasia.
  Journal
Nat Rev Cancer 6:292-306 (2006)
DOI:10.1038/nrc1836
Reference
PMID:16551846
  Authors
Chiloeches A, Marais R.
  Title
Is BRAF the Achilles' Heel of thyroid cancer?
  Journal
Clin Cancer Res 12:1661-4 (2006)
DOI:10.1158/1078-0432.CCR-06-0051
Reference
PMID:16946003
  Authors
Reddi HV, McIver B, Grebe SK, Eberhardt NL
  Title
The paired box-8/peroxisome proliferator-activated receptor-gamma oncogene in thyroid tumorigenesis.
  Journal
Endocrinology 148:932-5 (2007)
DOI:10.1210/en.2006-0926
Reference
PMID:17062879
  Authors
Santoro M, Melillo RM, Fusco A.
  Title
RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture.
  Journal
Eur J Endocrinol 155:645-653 (2006)
DOI:10.1530/eje.1.02289
Reference
PMID:16242838
  Authors
Pierotti MA, Greco A.
  Title
Oncogenic rearrangements of the NTRK1/NGF receptor.
  Journal
Cancer Lett 232:90-8 (2006)
DOI:10.1016/j.canlet.2005.07.043
Reference
PMID:16189702
  Authors
Sobrinho-Simoes M, Preto A, Rocha AS, Castro P, Maximo V, Fonseca E, Soares P.
  Title
Molecular pathology of well-differentiated thyroid carcinomas.
  Journal
Virchows Arch 447:787-93 (2005)
DOI:10.1007/s00428-005-0065-5
Reference
PMID:11165748
  Authors
Gimm O.
  Title
Thyroid cancer.
  Journal
Cancer Lett 163:143-56 (2001)
DOI:10.1016/S0304-3835(00)00697-2
Reference
PMID:12094241
  Authors
Williams D.
  Title
Cancer after nuclear fallout: lessons from the Chernobyl accident.
  Journal
Nat Rev Cancer 2:543-9 (2002)
DOI:10.1038/nrc845
Reference
PMID:16236521
  Authors
Steffen B, Muller-Tidow C, Schwable J, Berdel WE, Serve H.
  Title
The molecular pathogenesis of acute myeloid leukemia.
  Journal
Crit Rev Oncol Hematol 56:195-221 (2005)
DOI:10.1016/j.critrevonc.2004.10.012
Reference
PMID:12563308
  Authors
Tenen DG.
  Title
Disruption of differentiation in human cancer: AML shows the way.
  Journal
Nat Rev Cancer 3:89-101 (2003)
DOI:10.1038/nrc989
Reference
PMID:16146838
  Authors
Choudhary C, Muller-Tidow C, Berdel WE, Serve H.
  Title
Signal transduction of oncogenic Flt3.
  Journal
Int J Hematol 82:93-9 (2005)
DOI:10.1532/IJH97.05090
Reference
PMID:12951584
  Authors
Stirewalt DL, Radich JP.
  Title
The role of FLT3 in haematopoietic malignancies.
  Journal
Nat Rev Cancer 3:650-65 (2003)
DOI:10.1038/nrc1169
Reference
PMID:16642045
  Authors
Martelli AM, Nyakern M, Tabellini G, Bortul R, Tazzari PL, Evangelisti C, Cocco L.
  Title
Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia.
  Journal
Leukemia 20:911-28 (2006)
DOI:10.1038/sj.leu.2404245
Reference
PMID:15625120
  Authors
Lennartsson J, Jelacic T, Linnekin D, Shivakrupa R.
  Title
Normal and oncogenic forms of the receptor tyrosine kinase kit.
  Journal
Stem Cells 23:16-43 (2005)
DOI:10.1634/stemcells.2004-0117
Reference
PMID:11721960
  Authors
Lorsbach RB, Downing JR.
  Title
The role of the AML1 transcription factor in leukemogenesis.
  Journal
Int J Hematol 74:258-65 (2001)
DOI:10.1007/BF02982058
Reference
PMID:12468433
  Authors
Mizuki M, Schwable J, Steur C, Choudhary C, Agrawal S, Sargin B, Steffen B, Matsumura I, Kanakura Y, Bohmer FD, Muller-Tidow C, Berdel WE, Serve H.
  Title
Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations.
  Journal
Blood 101:3164-73 (2003)
DOI:10.1182/blood-2002-06-1677
Reference
PMID:17554387
  Authors
Mikesch JH, Steffen B, Berdel WE, Serve H, Muller-Tidow C.
  Title
The emerging role of Wnt signaling in the pathogenesis of acute myeloid leukemia.
  Journal
Leukemia 21:1638-47 (2007)
DOI:10.1038/sj.leu.2404732
Reference
PMID:16352814
  Authors
Mueller BU, Pabst T, Fos J, Petkovic V, Fey MF, Asou N, Buergi U, Tenen DG.
  Title
ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression.
  Journal
Blood 107:3330-8 (2006)
DOI:10.1182/blood-2005-07-3068
Reference
PMID:15719031
  Authors
Ren R.
  Title
Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia.
  Journal
Nat Rev Cancer 5:172-83 (2005)
DOI:10.1038/nrc1567
Reference
PMID:11071626
  Authors
Deininger MW, Goldman JM, Melo JV.
  Title
The molecular biology of chronic myeloid leukemia.
  Journal
Blood 96:3343-56 (2000)
Reference
PMID:14982876
  Authors
Calabretta B, Perrotti D.
  Title
The biology of CML blast crisis.
  Journal
Blood 103:4010-22 (2004)
DOI:10.1182/blood-2003-12-4111
Reference
PMID:10403855
  Authors
Faderl S, Talpaz M, Estrov Z, O'Brien S, Kurzrock R, Kantarjian HM.
  Title
The biology of chronic myeloid leukemia.
  Journal
N Engl J Med 341:164-72 (1999)
DOI:10.1056/NEJM199907153410306
Reference
PMID:15156182
  Authors
Mitani K.
  Title
Molecular mechanisms of leukemogenesis by AML1/EVI-1.
  Journal
Oncogene 23:4263-9 (2004)
DOI:10.1038/sj.onc.1207777
Reference
PMID:16484590
  Authors
Dong M, Blobe GC.
  Title
Role of transforming growth factor-beta in hematologic malignancies.
  Journal
Blood 107:4589-96 (2006)
DOI:10.1182/blood-2005-10-4169
Reference
PMID:9834202
  Authors
Kurokawa M, Mitani K, Imai Y, Ogawa S, Yazaki Y, Hirai H.
  Title
The t(3;21) fusion product, AML1/Evi-1, interacts with Smad3 and blocks transforming growth factor-beta-mediated growth inhibition of myeloid cells.
  Journal
Blood 92:4003-12 (1998)
Reference
PMID:12801837
  Authors
Brusa G, Benvenuti M, Mazzacurati L, Mancini M, Pattacini L, Martinelli G, Barbieri E, Greenberger JS, Baccarani M, Santucci MA.
  Title
p53 loss of function enhances genomic instability and accelerates clonal evolution of murine myeloid progenitors expressing the p(210)BCR-ABL tyrosine kinase.
  Journal
Haematologica 88:622-30 (2003)
Reference
PMID:11160144
  Authors
Baldwin AS.
  Title
Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB.
  Journal
J Clin Invest 107:241-6 (2001)
DOI:10.1172/JCI11991
Reference
PMID:12244301
  Authors
Shin I, Yakes FM, Rojo F, Shin NY, Bakin AV, Baselga J, Arteaga CL.
  Title
PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization.
  Journal
Nat Med 8:1145-52 (2002)
DOI:10.1038/nm759
Reference
PMID:15948971
  Authors
Tilli CM, Van Steensel MA, Krekels GA, Neumann HA, Ramaekers FC.
  Title
Molecular aetiology and pathogenesis of basal cell carcinoma.
  Journal
Br J Dermatol 152:1108-24 (2005)
DOI:10.1111/j.1365-2133.2005.06587.x
Reference
PMID:12588368
  Authors
Saldanha G, Fletcher A, Slater DN.
  Title
Basal cell carcinoma: a dermatopathological and molecular biological update.
  Journal
Br J Dermatol 148:195-202 (2003)
DOI:10.1046/j.1365-2133.2003.05151.x
Reference
PMID:15978322
  Authors
Daya-Grosjean L, Couve-Privat S.
  Title
Sonic hedgehog signaling in basal cell carcinomas.
  Journal
Cancer Lett 225:181-92 (2005)
DOI:10.1016/j.canlet.2004.10.003
Reference
PMID:15468170
  Authors
Tsai KY, Tsao H.
  Title
The genetics of skin cancer.
  Journal
Am J Med Genet C Semin Med Genet 131C:82-92 (2004)
DOI:10.1002/ajmg.c.30037
Reference
PMID:16881963
  Authors
Athar M, Tang X, Lee JL, Kopelovich L, Kim AL.
  Title
Hedgehog signalling in skin development and cancer.
  Journal
Exp Dermatol 15:667-77 (2006)
DOI:10.1111/j.1600-0625.2006.00473.x
Reference
PMID:16306523
  Authors
Rubin AI, Chen EH, Ratner D.
  Title
Basal-cell carcinoma.
  Journal
N Engl J Med 353:2262-9 (2005)
DOI:10.1056/NEJMra044151
Reference
PMID:11276000
  Authors
Saldanha G.
  Title
The Hedgehog signalling pathway and cancer.
  Journal
J Pathol 193:427-32 (2001)
DOI:10.1002/1096-9896(2000)9999:9999<::AID-PATH815>3.0.CO;2-N
Reference
PMID:15270885
  Authors
Saldanha G, Ghura V, Potter L, Fletcher A.
  Title
Nuclear beta-catenin in basal cell carcinoma correlates with increased proliferation.
  Journal
Br J Dermatol 151:157-64 (2004)
DOI:10.1111/j.1365-2133.2004.06048.x
Reference
PMID:14737121
  Authors
Pasca di Magliano M, Hebrok M.
  Title
Hedgehog signalling in cancer formation and maintenance.
  Journal
Nat Rev Cancer 3:903-11 (2003)
DOI:10.1038/nrc1229
Reference
PMID:15656799
  Authors
Reifenberger J, Wolter M, Knobbe CB, Kohler B, Schonicke A, Scharwachter C, Kumar K, Blaschke B, Ruzicka T, Reifenberger G.
  Title
Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas.
  Journal
Br J Dermatol 152:43-51 (2005)
DOI:10.1111/j.1365-2133.2005.06353.x
Reference
PMID:14556242
  Authors
Cohen MM Jr.
  Title
The hedgehog signaling network.
  Journal
Am J Med Genet A 123:5-28 (2003)
DOI:10.1002/ajmg.a.20495
Reference
PMID:11736900
  Authors
Yamazaki F, Aragane Y, Kawada A, Tezuka T.
  Title
Immunohistochemical detection for nuclear beta-catenin in sporadic basal cell carcinoma.
  Journal
Br J Dermatol 145:771-7 (2001)
DOI:10.1046/j.1365-2133.2001.04468.x
Reference
PMID:16054233
  Authors
Erb P, Ji J, Wernli M, Kump E, Glaser A, Buchner SA.
  Title
Role of apoptosis in basal cell and squamous cell carcinoma formation.
  Journal
Immunol Lett 100:68-72 (2005)
DOI:10.1016/j.imlet.2005.06.008
Reference
PMID:11130178
  Authors
Toftgard R.
  Title
Hedgehog signalling in cancer.
  Journal
Cell Mol Life Sci 57:1720-31 (2000)
DOI:10.1007/PL00000654
Reference
PMID:16822996
  Authors
Miller AJ, Mihm MC Jr.
  Title
Melanoma.
  Journal
N Engl J Med 355:51-65 (2006)
DOI:10.1056/NEJMra052166
Reference
PMID:12894244
  Authors
Chin L.
  Title
The genetics of malignant melanoma: lessons from mouse and man.
  Journal
Nat Rev Cancer 3:559-70 (2003)
DOI:10.1038/nrc1145
Reference
PMID:16750612
  Authors
Takata M, Saida T.
  Title
Genetic alterations in melanocytic tumors.
  Journal
J Dermatol Sci 43:1-10 (2006)
DOI:10.1016/j.jdermsci.2006.05.002
Reference
PMID:15841168
  Authors
Chudnovsky Y, Khavari PA, Adams AE.
  Title
Melanoma genetics and the development of rational therapeutics.
  Journal
J Clin Invest 115:813-24 (2005)
DOI:10.1172/JCI24808
Reference
PMID:16001050
  Authors
Merlino G.
  Title
Cancer biology: the weakest link?
  Journal
Nature 436:33-5 (2005)
DOI:10.1038/436033a
Reference
PMID:16001072
  Authors
Garraway LA, Widlund HR, Rubin MA, Getz G, Berger AJ, Ramaswamy S, Beroukhim R, Milner DA, Granter SR, Du J, Lee C, Wagner SN, Li C, Golub TR, Rimm DL, Meyerson ML, Fisher DE, Sellers WR.
  Title
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.
  Journal
Nature 436:117-22 (2005)
DOI:10.1038/nature03664
Reference
PMID:16899407
  Authors
Levy C, Khaled M, Fisher DE.
  Title
MITF: master regulator of melanocyte development and melanoma oncogene.
  Journal
Trends Mol Med 12:406-14 (2006)
DOI:10.1016/j.molmed.2006.07.008
Reference
PMID:15009714
  Authors
Tsao H, Goel V, Wu H, Yang G, Haluska FG.
  Title
Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma.
  Journal
J Invest Dermatol 122:337-41 (2004)
DOI:10.1046/j.0022-202X.2004.22243.x
Reference
PMID:11224709
  Authors
Gruss C, Herlyn M.
  Title
Role of cadherins and matrixins in melanoma.
  Journal
Curr Opin Oncol 13:117-23 (2001)
DOI:10.1097/00001622-200103000-00006
Reference
PMID:15721476
  Authors
Thompson JF, Scolyer RA, Kefford RF.
  Title
Cutaneous melanoma.
  Journal
Lancet 365:687-701 (2005)
DOI:10.1016/S0140-6736(05)17951-3
Reference
PMID:14695152
  Authors
Omholt K, Platz A, Kanter L, Ringborg U, Hansson J.
  Title
NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression.
  Journal
Clin Cancer Res 9:6483-8 (2003)
Reference
PMID:15557758
  Authors
Hussein MR.
  Title
The TP53 tumor suppressor gene and melanoma tumorigenesis: is there a relationship?
  Journal
Tumour Biol 25:200-7 (2004)
DOI:10.1159/000081103
Reference
PMID:10843728
  Authors
Lazar-Molnar E, Hegyesi H, Toth S, Falus A.
  Title
Autocrine and paracrine regulation by cytokines and growth factors in melanoma.
  Journal
Cytokine 12:547-54 (2000)
DOI:10.1006/cyto.1999.0614
Reference
PMID:16339096
  Authors
Cohen HT, McGovern FJ.
  Title
Renal-cell carcinoma.
  Journal
N Engl J Med 353:2477-90 (2005)
DOI:10.1056/NEJMra043172
Reference
PMID:15122209
  Authors
Pavlovich CP, Schmidt LS.
  Title
Searching for the hereditary causes of renal-cell carcinoma.
  Journal
Nat Rev Cancer 4:381-93 (2004)
DOI:10.1038/nrc1364
Reference
PMID:14634372
  Authors
Linehan WM, Walther MM, Zbar B.
  Title
The genetic basis of cancer of the kidney.
  Journal
J Urol 170:2163-72 (2003)
DOI:10.1097/01.ju.0000096060.92397.ed
Reference
PMID:14685170
  Authors
Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF.
  Title
Met, metastasis, motility and more.
  Journal
Nat Rev Mol Cell Biol 4:915-25 (2003)
DOI:10.1038/nrm1261
Reference
PMID:15611513
  Authors
Kim WY, Kaelin WG.
  Title
Role of VHL gene mutation in human cancer.
  Journal
J Clin Oncol 22:4991-5004 (2004)
DOI:10.1200/JCO.2004.05.061
Reference
PMID:17211469
  Authors
Sudarshan S, Linehan WM, Neckers L.
  Title
HIF and fumarate hydratase in renal cancer.
  Journal
Br J Cancer 96:403-7 (2007)
DOI:10.1038/sj.bjc.6603547
Reference
PMID:17287871
  Authors
Sudarshan S, Pinto PA, Neckers L, Linehan WM.
  Title
Mechanisms of disease: hereditary leiomyomatosis and renal cell cancer--a distinct form of hereditary kidney cancer.
  Journal
Nat Clin Pract Urol 4:104-10 (2007)
DOI:10.1038/ncpuro0711
Reference
PMID:12351585
  Authors
Bodmer D, van den Hurk W, van Groningen JJ, Eleveld MJ, Martens GJ, Weterman MA, van Kessel AG.
  Title
Understanding familial and non-familial renal cell cancer.
  Journal
Hum Mol Genet 11:2489-98 (2002)
DOI:10.1093/hmg/11.20.2489
Reference
PMID:17158541
  Authors
Mitra AP, Datar RH, Cote RJ.
  Title
Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification.
  Journal
J Clin Oncol 24:5552-64 (2006)
DOI:10.1200/JCO.2006.08.2073
Reference
PMID:16474624
  Authors
Wolff EM, Liang G, Jones PA.
  Title
Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer.
  Journal
Nat Clin Pract Urol 2:502-10 (2005)
DOI:10.1038/ncpuro0318
Reference
PMID:16110317
  Authors
Wu XR.
  Title
Urothelial tumorigenesis: a tale of divergent pathways.
  Journal
Nat Rev Cancer 5:713-25 (2005)
DOI:10.1038/nrc1697
Reference
PMID:11103787
  Authors
Brown NS, Jones A, Fujiyama C, Harris AL, Bicknell R.
  Title
Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors.
  Journal
Cancer Res 60:6298-302 (2000)
Reference
PMID:12850530
  Authors
Bellmunt J, Hussain M, Dinney CP.
  Title
Novel approaches with targeted therapies in bladder cancer. Therapy of bladder cancer by blockade of the epidermal growth factor receptor family.
  Journal
Crit Rev Oncol Hematol 46 Suppl:S85-104 (2003)
DOI:10.1016/S1040-8428(03)00067-2
Reference
PMID:17149381
  Authors
Sugano K, Kakizoe T.
  Title
Genetic alterations in bladder cancer and their clinical applications in molecular tumor staging.
  Journal
Nat Clin Pract Urol 3:642-52 (2006)
DOI:10.1038/ncpuro0649
Reference
PMID:15746962
  Authors
Dunn KL, Espino PS, Drobic B, He S, Davie JR.
  Title
The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling.
  Journal
Biochem Cell Biol 83:1-14 (2005)
DOI:10.1139/o04-121
Reference
PMID:15551095
  Authors
Williams SG, Stein JP.
  Title
Molecular pathways in bladder cancer.
  Journal
Urol Res 32:373-85 (2004)
DOI:10.1007/s00240-003-0345-y
Reference
PMID:12878745
  Authors
Nelson WG, De Marzo AM, Isaacs WB.
  Title
Prostate cancer.
  Journal
N Engl J Med 349:366-81 (2003)
DOI:10.1056/NEJMra021562
Reference
PMID:15724144
  Authors
Li L, Ittmann MM, Ayala G, Tsai MJ, Amato RJ, Wheeler TM, Miles BJ, Kadmon D, Thompson TC.
  Title
The emerging role of the PI3-K-Akt pathway in prostate cancer progression.
  Journal
Prostate Cancer Prostatic Dis 8:108-18 (2005)
DOI:10.1038/sj.pcan.4500776
Reference
PMID:16551847
  Authors
Pienta KJ, Bradley D.
  Title
Mechanisms underlying the development of androgen-independent prostate cancer.
  Journal
Clin Cancer Res 12:1665-71 (2006)
DOI:10.1158/1078-0432.CCR-06-0067
Reference
PMID:11900250
  Authors
Feldman BJ, Feldman D.
  Title
The development of androgen-independent prostate cancer.
  Journal
Nat Rev Cancer 1:34-45 (2001)
DOI:10.1038/35094009
Reference
PMID:15082523
  Authors
Heinlein CA, Chang C.
  Title
Androgen receptor in prostate cancer.
  Journal
Endocr Rev 25:276-308 (2004)
DOI:10.1210/er.2002-0032
Reference
PMID:9422516
  Authors
Koivisto P, Kolmer M, Visakorpi T, Kallioniemi OP.
  Title
Androgen receptor gene and hormonal therapy failure of prostate cancer.
  Journal
Am J Pathol 152:1-9 (1998)
Reference
PMID:10835690
  Authors
Zhao XY, Malloy PJ, Krishnan AV, Swami S, Navone NM, Peehl DM, Feldman D.
  Title
Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor.
  Journal
Nat Med 6:703-6 (2000)
DOI:10.1038/76287
Reference
PMID:10453277
  Authors
Macri E, Loda M.
  Title
Role of p27 in prostate carcinogenesis.
  Journal
Cancer Metastasis Rev 17:337-44 (1998)
DOI:10.1023/A:1006133620914
Reference
PMID:11750244
  Authors
Steers WD.
  Title
5alpha-reductase activity in the prostate.
  Journal
Urology 58:17-24; discussion 24 (2001)
DOI:10.1016/S0090-4295(01)01299-7
Reference
PMID:8069858
  Authors
Lin D, Meyer DJ, Ketterer B, Lang NP, Kadlubar FF.
  Title
Effects of human and rat glutathione S-transferases on the covalent DNA binding of the N-acetoxy derivatives of heterocyclic amine carcinogens in vitro: a possible mechanism of organ specificity in their carcinogenesis.
  Journal
Cancer Res 54:4920-6 (1994)
Reference
PMID:11527574
  Authors
Grimes CA, Jope RS.
  Title
The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling.
  Journal
Prog Neurobiol 65:391-426 (2001)
DOI:10.1016/S0301-0082(01)00011-9
Reference
PMID:15947972
  Authors
Ryan AJ, Susil B, Jobling TW, Oehler MK.
  Title
Endometrial cancer.
  Journal
Cell Tissue Res 322:53-61 (2005)
DOI:10.1007/s00441-005-1109-5
Reference
PMID:14747944
  Authors
Lax SF.
  Title
Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.
  Journal
Virchows Arch 444:213-23 (2004)
DOI:10.1007/s00428-003-0947-3
Reference
PMID:16508724
  Authors
Shiozawa T, Konishi I.
  Title
Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment.
  Journal
Int J Clin Oncol 11:13-21 (2006)
DOI:10.1007/s10147-005-0546-1
Reference
PMID:17028294
  Authors
Hecht JL, Mutter GL.
  Title
Molecular and pathologic aspects of endometrial carcinogenesis.
  Journal
J Clin Oncol 24:4783-91 (2006)
DOI:10.1200/JCO.2006.06.7173
Reference
PMID:11431710
  Authors
Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, Munoz J, Arguelles R, Machin P, Prat J.
  Title
Molecular pathology of endometrial hyperplasia and carcinoma.
  Journal
Hum Pathol 32:569-77 (2001)
DOI:10.1053/hupa.2001.25929
Reference
PMID:15284264
  Authors
Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH.
  Title
Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.
  Journal
J Clin Oncol 22:3126-32 (2004)
DOI:10.1200/JCO.2004.11.154
Reference
PMID:7585656
  Authors
Saffari B, Jones LA, el-Naggar A, Felix JC, George J, Press MF.
  Title
Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival.
  Journal
Cancer Res 55:5693-8 (1995)
Reference
PMID:16248975
  Authors
Kim D, Chung J.
  Title
Akt: versatile mediator of cell survival and beyond.
  Journal
J Biochem Mol Biol 35:106-15 (2002)
DOI:10.5483/bmbrep.2002.35.1.106
Reference
PMID:12711111
  Authors
Sanchez-Cespedes M.
  Title
Dissecting the genetic alterations involved in lung carcinogenesis.
  Journal
Lung Cancer 40:111-21 (2003)
DOI:10.1016/S0169-5002(03)00033-3
Reference
PMID:11720739
  Authors
Kaye FJ.
  Title
Molecular biology of lung cancer.
  Journal
Lung Cancer 34 Suppl 2:S35-41 (2001)
DOI:10.1016/S0169-5002(01)00342-7
Reference
PMID:12616528
  Authors
Shivapurkar N, Reddy J, Chaudhary PM, Gazdar AF.
  Title
Apoptosis and lung cancer: a review.
  Journal
J Cell Biochem 88:885-98 (2003)
DOI:10.1002/jcb.10440
Reference
PMID:11807782
  Authors
Sartorius UA, Krammer PH.
  Title
Upregulation of Bcl-2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines.
  Journal
Int J Cancer 97:584-92 (2002)
DOI:10.1002/ijc.10096
Reference
PMID:16064138
  Authors
Adhikary S, Eilers M.
  Title
Transcriptional regulation and transformation by Myc proteins.
  Journal
Nat Rev Mol Cell Biol 6:635-45 (2005)
DOI:10.1038/nrm1703
Reference
PMID:11463388
  Authors
Spruck C, Strohmaier H, Watson M, Smith AP, Ryan A, Krek TW, Reed SI.
  Title
A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1.
  Journal
Mol Cell 7:639-50 (2001)
DOI:10.1016/S1097-2765(01)00210-6
Reference
PMID:15109562
  Authors
Buttery RC, Rintoul RC, Sethi T.
  Title
Small cell lung cancer: the importance of the extracellular matrix.
  Journal
Int J Biochem Cell Biol 36:1154-60 (2004)
DOI:10.1016/S1357-2725(03)00261-9
Reference
PMID:11559746
  Authors
Yamada KM, Araki M.
  Title
Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis.
  Journal
J Cell Sci 114:2375-82 (2001)
Reference
PMID:11905738
  Authors
Rintoul RC, Sethi T.
  Title
The role of extracellular matrix in small-cell lung cancer.
  Journal
Lancet Oncol 2:437-42 (2001)
DOI:10.1016/S1470-2045(00)00421-6
Reference
PMID:12243753
  Authors
Ekedahl J, Joseph B, Grigoriev MY, Muller M, Magnusson C, Lewensohn R, Zhivotovsky B.
  Title
Expression of inhibitor of apoptosis proteins in small- and non-small-cell lung carcinoma cells.
  Journal
Exp Cell Res 279:277-90 (2002)
DOI:10.1006/excr.2002.5608
Reference
PMID:12379883
  Authors
Osada H, Takahashi T.
  Title
Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer.
  Journal
Oncogene 21:7421-34 (2002)
DOI:10.1038/sj.onc.1205802
Reference
PMID:12741677
  Authors
Yokota J, Nishioka M, Tani M, Kohno T.
  Title
Genetic alterations responsible for metastatic phenotypes of lung cancer cells.
  Journal
Clin Exp Metastasis 20:189-93 (2003)
DOI:10.1023/a:1022978932215
Reference
PMID:16870043
  Authors
Aviel-Ronen S, Blackhall FH, Shepherd FA, Tsao MS.
  Title
K-ras mutations in non-small-cell lung carcinoma: a review.
  Journal
Clin Lung Cancer 8:30-8 (2006)
DOI:10.3816/CLC.2006.n.030
Reference
PMID:15948711
  Authors
Pfeifer GP, Dammann R.
  Title
Methylation of the tumor suppressor gene RASSF1A in human tumors.
  Journal
Biochemistry (Mosc) 70:576-83 (2005)
DOI:10.1007/s10541-005-0151-y
Reference
PMID:11902573
  Authors
Altucci L, Gronemeyer H.
  Title
The promise of retinoids to fight against cancer.
  Journal
Nat Rev Cancer 1:181-93 (2001)
DOI:10.1038/35106036
Reference
PMID:10944551
  Authors
Virmani AK, Rathi A, Zochbauer-Muller S, Sacchi N, Fukuyama Y, Bryant D, Maitra A, Heda S, Fong KM, Thunnissen F, Minna JD, Gazdar AF.
  Title
Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas.
  Journal
J Natl Cancer Inst 92:1303-7 (2000)
DOI:10.1093/jnci/92.16.1303
Reference
PMID:12867060
  Authors
Hirsch FR, Scagliotti GV, Langer CJ, Varella-Garcia M, Franklin WA.
  Title
Epidermal growth factor family of receptors in preneoplasia and lung cancer: perspectives for targeted therapies.
  Journal
Lung Cancer 41 Suppl 1:S29-42 (2003)
DOI:10.1016/S0169-5002(03)00137-5
Reference
PMID:16112428
  Authors
Panani AD, Roussos C.
  Title
Cytogenetic and molecular aspects of lung cancer.
  Journal
Cancer Lett 239:1-9 (2006)
DOI:10.1016/j.canlet.2005.06.030
Reference
PMID:12407699
  Authors
Mitsuuchi Y, Testa JR.
  Title
Cytogenetics and molecular genetics of lung cancer.
  Journal
Am J Med Genet 115:183-8 (2002)
DOI:10.1002/ajmg.10692
Reference
PMID:15942304
  Authors
Breuer RH, Postmus PE, Smit EF.
  Title
Molecular pathology of non-small-cell lung cancer.
  Journal
Respiration 72:313-30 (2005)
DOI:10.1159/000085376
Reference
PMID:11895903
  Authors
Piyathilake CJ, Frost AR, Manne U, Weiss H, Bell WC, Heimburger DC, Grizzle WE.
  Title
Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung.
  Journal
Clin Cancer Res 8:734-44 (2002)
Reference
PMID:16189154
  Authors
Awaya H, Takeshima Y, Furonaka O, Kohno N, Inai K.
  Title
Gene amplification and protein expression of EGFR and HER2 by chromogenic in situ hybridisation and immunohistochemistry in atypical adenomatous hyperplasia and adenocarcinoma of the lung.
  Journal
J Clin Pathol 58:1076-80 (2005)
DOI:10.1136/jcp.2004.025585
Reference
PMID:21193867
  Authors
Lappano R, Maggiolini M
  Title
G protein-coupled receptors: novel targets for drug discovery in cancer.
  Journal
Nat Rev Drug Discov 10:47-60 (2011)
DOI:10.1038/nrd3320
Reference
PMID:24508914
  Authors
O'Hayre M, Degese MS, Gutkind JS
  Title
Novel insights into G protein and G protein-coupled receptor signaling in cancer.
  Journal
Curr Opin Cell Biol 27:126-35 (2014)
DOI:10.1016/j.ceb.2014.01.005
Reference
PMID:17251915
  Authors
Dorsam RT, Gutkind JS
  Title
G-protein-coupled receptors and cancer.
  Journal
Nat Rev Cancer 7:79-94 (2007)
DOI:10.1038/nrc2069
Related
pathway
gvr03320  PPAR signaling pathway
gvr04010  MAPK signaling pathway
gvr04020  Calcium signaling pathway
gvr04024  cAMP signaling pathway
gvr04060  Cytokine-cytokine receptor interaction
gvr04066  HIF-1 signaling pathway
gvr04110  Cell cycle
gvr04115  p53 signaling pathway
gvr04150  mTOR signaling pathway
gvr04151  PI3K-Akt signaling pathway
gvr04210  Apoptosis
gvr04310  Wnt signaling pathway
gvr04330  Notch signaling pathway
gvr04340  Hedgehog signaling pathway
gvr04350  TGF-beta signaling pathway
gvr04370  VEGF signaling pathway
gvr04510  Focal adhesion
gvr04512  ECM-receptor interaction
gvr04520  Adherens junction
gvr04630  JAK-STAT signaling pathway
gvr04915  Estrogen signaling pathway
KO pathway
ko05200   
LinkDB

DBGET integrated database retrieval system